Security key
00430K865
Grace Therapeutics, Inc. - Common Stock (ACST)
CUSIP: 00430K865
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,152,387
- Total 13F value
- $6,299,610
- Share change
- +886,955
- SEC-reported price per share
- $2.93
- Number of holders
- 12
- Value change
- +$2,590,846
- Number of buys
- 7
- Number of sells
- 2
- Shares outstanding
- 16,612,245
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
12
Top holders
10
ACST full security history
Ownership snapshot
Full 13F holder table
Grace Therapeutics, Inc. SEC filings
Grace Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ACST - Grace Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $1,706,549
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
AIGH Capital Management LLC has the largest disclosed position value at $1.71M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value
Top 5
ADAR1 Capital Management, LLC
$744.5K
AIGH Capital Management LLC
$1.71M
BANK OF AMERICA CORP /DE/
$1.69M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$126.4K
ROYAL BANK OF CANADA
$43K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$744,530
217,381 shares
|
— | 31 Mar 2024 |
| Rajitha Grace 2018 Irrevocable Trust |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
4,689,547 shares
|
— | 27 Aug 2021 |
| AIGH Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$1,706,549
497,359 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$1,694,341
494,698 shares
|
— | 31 Mar 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$126,443
36,650 shares
|
— | 31 Mar 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
—
denominator unverified
|
$43,000
12,584 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
2,152,387
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q2 2024 holders
12
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|